The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
NexImmune, Inc(NASDAQ:NEXI) 
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nan...
Website: http://www.neximmune.com
Founded: 2011
CEO: Scott Carmer
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
NexImmune Days Payable Outstanding ttm (DPO)
NexImmune Days Inventory Outstanding ttm (DIO)
NexImmune Op Cashflow Per Share ttm
NexImmune Free Cashflow Per Share ttm
NexImmune Cash Per Share ttm
NexImmune (GAAP) P/E ratio ttm
NexImmune P/B ratio ttm
No extra charts and metrics for this ticker.